Taylor Sandison - 29 Dec 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Chief Medical Officer
Signature: /s/ Taylor Sandison
Issuer symbol: CDTX
Transactions as of: 29 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2022, 19:22:22 UTC
Previous filing: 04 Oct 2021
Next filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Options Exercise	$0	+15,600	+6.5%	$0.000000	256,231	29 Dec 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Restricted Stock Unit	Options Exercise	$0	-10,000	-44%	$0.000000	12,500	29 Dec 2021	Common Stock	10,000		Direct	F3, F4
transaction	CDTX	Restricted Stock Unit	Options Exercise	$0	-5,600	-47%	$0.000000	6,300	29 Dec 2021	Common Stock	5,600		Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2	Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3	Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4	On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
F5	On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.